The Ensign Group, Inc. ENSG announced that its board of directors has approved a $60 million increase to its existing stock repurchase authorization, raising total buyback capacity to $100 million from $40 million. Management expects to begin repurchasing shares under the expanded program in the near term through open-market transactions, privately negotiated deals or block trades.
The move follows a strong first-quarter 2026 performance and reflects Ensign's financial strength. ENSG ended the first quarter of 2026 with $539.5 million in cash and cash equivalents, up from $503.9 million at the end of 2025. Operating cash flow increased nearly 39% year over year to $100.2 million, while available capacity under its revolving credit facility totaled $591.6 million. Following first-quarter results, management also raised its 2026 earnings guidance, reinforcing expectations for continued business momentum.
Share repurchases reduce the number of shares outstanding, which can support EPS growth and increase the ownership stake of existing shareholders. Ensign continues to pursue acquisitions alongside shareholder-return initiatives, indicating that management is comfortable funding both expansion efforts and buybacks at the same time. The company's return on capital of 15.78% significantly exceeded the industry average of 3.09%, highlighting its track record of deploying capital efficiently.
The expanded authorization underscores management's optimism regarding Ensign's long-term earnings and cash-flow prospects. While the pace and timing of repurchases will depend on market conditions, the program provides additional flexibility to return capital to shareholders while preserving the company's disciplined approach to growth.
How Are Peers Deploying Capital?
PACS Group, Inc. PACS and The Pennant Group, Inc. PNTG, two notable players in the Medical space, are also actively deploying capital to support shareholder value and long-term growth.
Earlier in 2026, PACS Group authorized a $250 million share repurchase program, signaling management's willingness to return capital to shareholders while maintaining flexibility for future growth. PACS continues to invest in facility development and acquisition opportunities across the post-acute care market.
In contrast, The Pennant Group has focused its capital deployment on acquisitions and organic expansion rather than share repurchases. PNTG continues to grow its home health, hospice and senior living footprint through strategic investments.
ENSG’s Stock Price Performance, Valuation & Estimates
Shares of Ensign have lost 2% over the past year against the industry’s 1.6% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, ENSG trades at a forward price-to-sales ratio of 1.45X, down from the industry average of 2.23X. ENSG carries a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Ensign Group’s 2026 earnings is pegged at $7.53 per share, implying a 14.6% jump from the year-ago period’s level.
Image Source: Zacks Investment Research
ENSG currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Ensign Group, Inc. (ENSG): Free Stock Analysis Report
The Pennant Group, Inc. (PNTG): Free Stock Analysis Report
PACS Group, Inc. (PACS): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).